Two health sciences researchers receive Canada Foundation for Innovation funding

September 23, 2022 by Brighter World

Old drug, new trick: Researchers find combining antiviral drugs and antibody therapy could treat seasonal flu and help prevent next flu pandemic

August 18, 2022 by McMaster's Brighter World

Dr. John Whitney wins 2022 ACS Infectious Diseases Young Investigator Award

August 12, 2022

MIRC researchers develop an inhaled vaccine

February 9, 2022 by McMaster's Brighter World

Researchers from MIRC confirm newly developed inhaled vaccine delivers broad protection against SARS-CoV-2, variants of concern.

Biochemistry and Biomedical Sciences Summer Scholars Program (SSP)

January 25, 2022

Human trials begin for promising new inhaled COVID-19 vaccines designed to combat variants of concern

December 7, 2021 by Michelle Donovan

Human trials are set to begin for two next-generation COVID-19 vaccines developed by a team of scientists at McMaster University. These are two of the very few COVID-19 vaccines being developed in Canada. Phase 1 of the clinical trials was recently approved by Health Canada.

Meet the researchers behind McMaster’s inhaled COVID-19 vaccines

December 7, 2021

From left to right: Co-principal investigator Matthew Miller; Fiona Smaill, professor of Pathology and Molecular Medicine and leader of the clinical trial; Zhou Xing, co-principal investigator and professor in the Department of Medicine; and Brian Lichty, associate professor in the Department of Medicine.

World’s most cited researchers includes 18 from Faculty of Health Sciences

December 1, 2021

Eighteen Faculty of Health Sciences (FHS) researchers are among 20 McMaster University-affiliated scientists recognized as being among the top one per cent of scientists in the world according to their citations.

Fall 2021 Convocation: Meet Governor General Academic Gold Medal winner Beth Culp

November 29, 2021

Home ice: Star researcher back at Mac to pioneer use of AI to fight antibiotic resistance

November 21, 2021 by Kara Aaserud

Jon Stokes is using creative methods and tools like artificial intelligence to fundamentally transform antibiotic discovery research as we know it

McMaster-led study links stress to Crohn’s disease flare-ups

November 18, 2021

A possible link between psychological stress and Crohn’s disease flare-ups has been identified by a McMaster University-led study.

Bounce at McMaster - Dr. Deborah Sloboda on Being Seen as a Whole Person Who Has a Life Outside of the Lab

November 10, 2021

Karen Mossman named one of the 100 Most Powerful Women in Canada

October 26, 2021 by McMaster Daily News

Karen Mossman's name has now been added to the list of the 100 Most Powerful Women in Canada, joining a cadre of the country’s highest achieving female leaders in the private, public, and not-for-profit sectors.

McMaster professors join Canadian Academy of Health Sciences

September 14, 2021

Five professors of the Faculty of Health Sciences are joining the Canadian Academy of Health Sciences (CAHS) as fellows. This election is considered the highest recognition of excellence in Canadian academic health sciences.

McMaster biomed students tout anti-COVID molecular medium

July 29, 2021

A molecular medium that deactivates the COVID-19 virus will keep lab techs safe and help labs run smoothly. But key to its commercial success are two McMaster students and a robust Hamilton Life Sciences Eco-System.

Researchers discover unique ‘spider web’ mechanism that traps, kills viruses such as SARS-CoV-2 and influenza

June 29, 2021 by Michelle Donovan

Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19.

McMaster COVID-19 rapid home test headed to market

June 23, 2021

A COVID-19 ‘spit test’ that can deliver results in 10 minutes and be taken at home is rolling out worldwide after being developed by scientists at McMaster University.

McMaster scientist wins U.S. award for infectious disease research

June 21, 2021 by Blake Dillon

McMaster University’s John Whitney has been named a 2021 Investigator in the Pathogenesis of Infectious Disease (PATH) by the Burroughs Wellcome Fund (BWF), a U.S.-based non-profit medical research organization.

Flu-fighter: Researchers develop a new vaccine to broaden and boost protection offered by seasonal flu shots

May 26, 2021 by Michelle Donovan

Researchers from McMaster University and the University of Buffalo have developed an experimental new vaccine which can provide significantly better protection from seasonal flu and could be a bridge to long-lasting universal vaccines in the future.

PBS interview: Gerry Wright on growing antibiotic resistance

May 25, 2021

Could mRNA vaccines be used to combat other diseases like cancer?

May 25, 2021

Bones and biofilms: Researchers Kathryn Grandfield, John Whitney awarded prestigious HFSP grants

May 25, 2021

Bacteria do not colonize the gut before birth, says collaborative study

May 10, 2021

New research led by scientists from McMaster University and Charité – Universitätsmedizin Berlin in Germany has found that that colonization of infants’ guts occurs during and after their births, and not before.

McMaster researcher receives $1.5M for international study of microbial communities

April 20, 2021 by Blake Dillon

An international team of early-career scientists, which includes McMaster University’s John Whitney, has received more than $1.5 million in funding from the International Human Frontier Science Program Organization (HFSP).